tradingkey.logo
tradingkey.logo
Pesquisar

Integra Lifesciences Holdings Corp

IART
Adicionar à lista de desejos
14.100USD
-0.400-2.76%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
1.10BValor de mercado
PerdaP/L TTM

Integra Lifesciences Holdings Corp

14.100
-0.400-2.76%

Mais detalhes de Integra Lifesciences Holdings Corp Empresa

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Informações de Integra Lifesciences Holdings Corp

Código da empresaIART
Nome da EmpresaIntegra Lifesciences Holdings Corp
Data de listagemAug 16, 1995
CEOPoul (Mojdeh)
Número de funcionários4396
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 16
Endereço1100 Campus Road
CidadePRINCETON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08540
Telefone16092750500
Sitehttps://www.integralife.com/
Código da empresaIART
Data de listagemAug 16, 1995
CEOPoul (Mojdeh)

Executivos da empresa Integra Lifesciences Holdings Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Neurosurgery
827.67M
50.61%
Wound Reconstruction and Care
323.49M
19.78%
Instruments
206.47M
12.63%
ENT
166.37M
10.17%
Private Label
111.25M
6.80%
Por RegiãoUSD
Nome
Receita
Proporção
United States
1.20B
73.67%
Asia Pacific
189.25M
11.57%
Europe
162.67M
9.95%
Rest of World
78.58M
4.81%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Neurosurgery
827.67M
50.61%
Wound Reconstruction and Care
323.49M
19.78%
Instruments
206.47M
12.63%
ENT
166.37M
10.17%
Private Label
111.25M
6.80%

Distribuição de ações

Atualizado em: qua, 13 de mai
Atualizado em: qua, 13 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
12.09%
TRU ST Partnership, L.P.
10.95%
Rubric Capital Management LP
9.97%
Vanguard Portfolio Management, LLC
4.74%
Fuller & Thaler Asset Management Inc.
4.67%
Outro
57.59%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
12.09%
TRU ST Partnership, L.P.
10.95%
Rubric Capital Management LP
9.97%
Vanguard Portfolio Management, LLC
4.74%
Fuller & Thaler Asset Management Inc.
4.67%
Outro
57.59%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
37.70%
Investment Advisor
36.17%
Hedge Fund
17.97%
Corporation
10.95%
Research Firm
3.47%
Individual Investor
3.46%
Pension Fund
1.65%
Bank and Trust
0.48%
Family Office
0.14%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
574
82.80M
106.43%
-14.51M
2025Q4
584
74.73M
95.94%
-24.99M
2025Q3
583
73.55M
94.42%
-25.07M
2025Q2
600
89.38M
114.72%
-18.72M
2025Q1
635
87.01M
111.97%
-18.30M
2024Q4
636
81.93M
106.10%
-20.27M
2024Q3
638
82.93M
106.93%
-12.58M
2024Q2
628
84.82M
107.92%
-1.75M
2024Q1
613
79.36M
101.18%
-3.69M
2023Q4
597
79.81M
101.26%
-5.74M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
9.40M
12.07%
+117.91K
+1.27%
Dec 31, 2025
TRU ST Partnership, L.P.
8.52M
10.93%
--
--
Feb 28, 2025
Rubric Capital Management LP
7.75M
9.95%
+100.00K
+1.31%
Dec 31, 2025
Fuller & Thaler Asset Management Inc.
3.64M
4.67%
-278.08K
-7.10%
Dec 31, 2025
Invesco Advisers, Inc.
3.18M
4.08%
-1.27K
-0.04%
Dec 31, 2025
State Street Investment Management (US)
2.81M
3.61%
+21.72K
+0.78%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
3.09M
3.96%
-96.93K
-3.04%
Dec 31, 2025
Boston Management and Research
2.74M
3.52%
--
--
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares Neuroscience and Healthcare ETF
1.44%
State Street SPDR S&P Health Care Equipment ETF
1.39%
ROBO Global Healthcare Technology & Innovation ETF
1.02%
Invesco S&P SmallCap Health Care ETF
0.49%
Invesco NASDAQ Future Gen 200 ETF
0.43%
Inspire Small/Mid Cap ESG ETF
0.19%
Royce Quant Small-Cap Quality Value ETF
0.13%
Principal U.S. Small-Cap ETF
0.13%
iShares S&P Small-Cap 600 Value ETF
0.12%
State Street SPDR S&P 600 Small Cap Value ETF
0.11%
Ver Mais
iShares Neuroscience and Healthcare ETF
Proporção1.44%
State Street SPDR S&P Health Care Equipment ETF
Proporção1.39%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.02%
Invesco S&P SmallCap Health Care ETF
Proporção0.49%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.43%
Inspire Small/Mid Cap ESG ETF
Proporção0.19%
Royce Quant Small-Cap Quality Value ETF
Proporção0.13%
Principal U.S. Small-Cap ETF
Proporção0.13%
iShares S&P Small-Cap 600 Value ETF
Proporção0.12%
State Street SPDR S&P 600 Small Cap Value ETF
Proporção0.11%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI